TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14715 · May 17

#python#ai#ai_art#art#asset_generator#chatbot#deep_learning#desktop_app#image_generation#mistral#multimodal#privacy#pygame#pyside6#python#self_hosted#speech_to_text#stable_diffusion#text_to_image#text_to_speech#text_to_speech_app AI Runner is a tool that lets you use AI on your own computer without needing the internet. It can do many things like **voice chatbots**, **text-to-image** generation, and **image editing**. You can also make AI personalities for more interesting conversations. It runs fast and securely, keeping your data private. To use AI Runner, you need a good computer with a strong GPU, like an NVIDIA RTX 3060 or better. This helps keep your data safe and makes AI tasks faster. https://github.com/Capsize-Games/airunner

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment